Marier, J., Trinh, M., Pheng, L. H., Palleja, S. M., & Martin, D. E. (2011). Pharmacokinetics and Pharmacodynamics of TBR-652, a Novel CCR5 Antagonist, in HIV-1-Infected, Antiretroviral Treatment-Experienced, CCR5 Antagonist-Naïve Patients. American Society for Microbiology.
Style de citation ChicagoMarier, Jean-Francois, MyMy Trinh, Leng Hong Pheng, Sandra M. Palleja, et David E. Martin. Pharmacokinetics and Pharmacodynamics of TBR-652, a Novel CCR5 Antagonist, in HIV-1-Infected, Antiretroviral Treatment-Experienced, CCR5 Antagonist-Naïve Patients. American Society for Microbiology, 2011.
Style de citation MLAMarier, Jean-Francois, et al. Pharmacokinetics and Pharmacodynamics of TBR-652, a Novel CCR5 Antagonist, in HIV-1-Infected, Antiretroviral Treatment-Experienced, CCR5 Antagonist-Naïve Patients. American Society for Microbiology, 2011.